Literature DB >> 26303249

Hepatitis C virus infection: accessing drug treatment.

Dan Smyth1, Duncan Webster2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26303249      PMCID: PMC4610830          DOI: 10.1503/cmaj.150652

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.

Authors:  Daniel John Smyth; Duncan Webster; Lisa Barrett; Mark MacMillan; Lisa McKnight; Frank Schweiger
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

Authors:  Timothy R Morgan; Marc G Ghany; Hae-Young Kim; Kristin K Snow; Mitchell L Shiffman; Jennifer L De Santo; William M Lee; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag; Chihiro Morishima; Karen L Lindsay; Anna S F Lok
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

5.  A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.

Authors:  Amit G Singal; Michael L Volk; Donald Jensen; Adrian M Di Bisceglie; Philip S Schoenfeld
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-27       Impact factor: 11.382

6.  Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Authors:  Stefan Zeuzem; Ira M Jacobson; Tolga Baykal; Rui T Marinho; Fred Poordad; Marc Bourlière; Mark S Sulkowski; Heiner Wedemeyer; Edward Tam; Paul Desmond; Donald M Jensen; Adrian M Di Bisceglie; Peter Varunok; Tarek Hassanein; Junyuan Xiong; Tami Pilot-Matias; Barbara DaSilva-Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

7.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Authors:  Nezam Afdhal; Stefan Zeuzem; Paul Kwo; Mario Chojkier; Norman Gitlin; Massimo Puoti; Manuel Romero-Gomez; Jean-Pierre Zarski; Kosh Agarwal; Peter Buggisch; Graham R Foster; Norbert Bräu; Maria Buti; Ira M Jacobson; G Mani Subramanian; Xiao Ding; Hongmei Mo; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Alessandra Mangia; Patrick Marcellin
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

8.  Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Authors:  Jordan J Feld; Kris V Kowdley; Eoin Coakley; Samuel Sigal; David R Nelson; Darrell Crawford; Ola Weiland; Humberto Aguilar; Junyuan Xiong; Tami Pilot-Matias; Barbara DaSilva-Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

9.  ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.

Authors:  Fred Poordad; Christophe Hezode; Roger Trinh; Kris V Kowdley; Stefan Zeuzem; Kosh Agarwal; Mitchell L Shiffman; Heiner Wedemeyer; Thomas Berg; Eric M Yoshida; Xavier Forns; Sandra S Lovell; Barbara Da Silva-Tillmann; Christine A Collins; Andrew L Campbell; Thomas Podsadecki; Barry Bernstein
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

Review 10.  Burden of disease and cost of chronic hepatitis C infection in Canada.

Authors:  Robert P Myers; Mel Krajden; Marc Bilodeau; Kelly Kaita; Paul Marotta; Kevork Peltekian; Alnoor Ramji; Chris Estes; Homie Razavi; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05
View more
  3 in total

1.  Family medicine-directed hepatitis C care and barriers to treatment: a mixed-methods study.

Authors:  Zoë von Aesch; Amy Craig-Neil; Hemant Shah; Tony Antoniou; Christopher Meaney; Andrew D Pinto
Journal:  CMAJ Open       Date:  2021-03-08

2.  The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.

Authors:  Huiting Ma; Conrado Franco Villalobos; Martin St-Jean; Oghenowede Eyawo; Miriam Ruth Lavergne; Lianping Ti; Mark W Hull; Benita Yip; Lang Wu; Robert S Hogg; Rolando Barrios; Jean A Shoveller; Julio S G Montaner; Viviane D Lima
Journal:  BMC Health Serv Res       Date:  2018-05-02       Impact factor: 2.655

Review 3.  Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment.

Authors:  Caroline O'Keefe-Markman; Kristina Dawn Lea; Christopher McCabe; Elaine Hyshka; Tania Bubela
Journal:  BMC Public Health       Date:  2020-01-20       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.